Navigation

Proteinuria (protein in the urine)

Автор: ,

Understanding Proteinuria (Protein in the Urine)

Proteinuria is defined as the presence of an abnormal amount of protein in the urine. It is a key indicator of kidney health and can be a sign of underlying kidney disease or other systemic conditions. While a small amount of protein is normally filtered by the kidneys, most of it is reabsorbed by the renal tubules, resulting in very low levels of protein in the final urine of healthy individuals.

 

Definition and Physiology of Protein Filtration

Under physiological conditions, the passage of proteins from the blood through the glomerular filter of the kidneys into the tubular filtrate is a tightly regulated process. This filtration is determined by several factors:

  • Pore Size of the Glomerular Basement Membrane (GBM): The GBM acts as a physical barrier, restricting the passage of larger molecules.
  • Molecular Weight (MW) of the Protein: Smaller proteins (like albumin, MW ~69 kDa) are filtered to a greater extent than very large proteins (like IgM, MW ~900 kDa).
  • Shape and Electric Charge of Protein Molecules: The GBM has a negative charge, which repels negatively charged proteins like albumin, further limiting their filtration.
  • Concentration Gradient: The relationship between the concentration of protein in the blood plasma and in the glomerular filtrate.

Normally, less than 150 mg of total protein and less than 30 mg of albumin are excreted in the urine per 24 hours. These amounts are usually too low to be detected by standard qualitative urine dipstick tests.

 

Mechanisms Leading to Increased Proteinuria

The presence of detectable protein in the urine (proteinuria) signifies a disruption in these normal processes and does not always mean that the protein is solely of renal origin (i.e., due to kidney damage). While proteinuria is a cardinal symptom of kidney disease, it can also indicate other pathological conditions in the body. An increase in proteinuria can result from one or more of the following mechanisms:

  • Glomerular Damage: Lesions affecting the glomerular basement membrane and podocytes (specialized epithelial cells of the nephron capsule) increase the permeability of the glomerular filter, allowing excessive amounts of plasma proteins (especially albumin) to leak into the filtrate. This is termed glomerular proteinuria.
  • Impaired Tubular Reabsorption: Damage to the renal tubules can impair their ability to reabsorb the small amounts of protein that are normally filtered. This leads to tubular proteinuria, often characterized by the presence of low-molecular-weight proteins.
  • Overflow Proteinuria (Prerenal): Filtration of excessive amounts of abnormal, low-molecular-weight plasma proteins (paraproteins, e.g., Bence Jones proteins in multiple myeloma; or myoglobin in rhabdomyolysis; or free hemoglobin in intravascular hemolysis). These proteins, due to their large quantity or unique characteristics, overwhelm the reabsorptive capacity of the tubules and are not completely reabsorbed.
  • Increased Secretion (Postrenal): Increased secretion of proteins (such as mucus, Tamm-Horsfall protein, or inflammatory proteins) by the epithelial cells of the kidneys, lower urinary tract (ureters, bladder, urethra), or auxiliary glands (e.g., prostate) can contribute to proteinuria. This is often seen with infections or inflammation of the lower urinary tract.
A urinalysis is a fundamental urine test commonly performed to detect various conditions, including proteinuria (protein in the urine), which can signify urinary tract infections, kidney disease, or systemic issues like diabetes.

 

Classification and Types of Proteinuria

Proteinuria can be classified based on its origin and underlying mechanism. The main types are prerenal, renal, and postrenal proteinuria.

 

Prerenal Proteinuria (Overflow Proteinuria)

Prerenal proteinuria is characterized by the passage of abnormal, typically low-molecular-weight plasma proteins through an intact (undamaged) renal glomerular filter into the urine. This occurs when the concentration of these specific proteins in the blood is so high that they "overflow" the reabsorptive capacity of the renal tubules.

Prerenal proteinuria is observed in conditions such as:

  • Monoclonal Gammopathies (e.g., Multiple Myeloma, Waldenström's Macroglobulinemia): Due to increased synthesis and filtration of monoclonal immunoglobulin light chains (Bence Jones proteins).
  • Intravascular Hemolysis (e.g., in severe hemolytic anemias): Leads to increased free hemoglobin in the plasma (hemoglobinemia), which, if exceeding haptoglobin binding capacity, is filtered by the glomeruli, causing hemoglobinuria (a form of proteinuria as hemoglobin is a protein).
  • Rhabdomyolysis (Muscle Injury): Necrotic, traumatic, toxic, or other muscle injuries lead to the release of myoglobin into the bloodstream (myoglobinemia). Myoglobin is filtered by the kidneys, resulting in myoglobinuria (also a form of proteinuria).

These conditions, particularly when involving high concentrations of filtered proteins (like Bence Jones proteins, hemoglobin, or myoglobin), may initially not cause damage to the renal nephron if present at low concentrations or for a very short duration. However, high concentrations and/or a long-term pathological process can eventually lead to damage to the renal tubules (e.g., "myeloma kidney," "heme pigment nephropathy") and impairment of the renal filter, potentially culminating in acute kidney injury (acute renal failure).

 

Renal Proteinuria

Renal proteinuria originates from the kidney itself and is the most common type associated with kidney disease. It is further divided into functional and pathological (organic) proteinuria.

 

Functional (Transient/Benign) Proteinuria

This type of proteinuria is usually mild (protein excretion typically does not exceed 1-2 g/day, often much less), transient, and not associated with underlying kidney disease. It often resolves when the precipitating factor is removed. Functional proteinuria is observed more often in individuals aged 20-30 years. Types include:

  • Transient Proteinuria: Occurs temporarily with certain physiological stresses.
  • Exercise-Induced Proteinuria (Working or Tension Proteinuria): Can occur after strenuous physical exertion.
  • Febrile Proteinuria: Associated with fever from any cause.
  • Toxic Proteinuria: Transient proteinuria due to exposure to certain toxins or as a reaction to some medications.
  • Orthostatic (Postural) Proteinuria: Protein is excreted in the urine only when the person is in an upright (orthostatic) position and disappears when they are recumbent (lying down). It is common in adolescents and young adults and is generally considered benign.
  • Hyperlordotic Proteinuria: Related to exaggerated lumbar lordosis.
  • Congestive (Stagnant) Proteinuria: Can occur with conditions causing renal venous congestion, such as severe congestive heart failure. This type is characterized by a decrease in the amount of urine (oliguria) with a high specific gravity, and the presence of protein (1-2 g/L, sometimes even higher, up to 10 g/day in severe cases). Impaired renal hemodynamics can lead to ischemic proteinuria, which develops as a result of a change in the electrical charge of albumin molecules adsorbed on the pores of the glomerular membrane and is accompanied by albuminuria. Ischemic proteinuria can occur with cardiac decompensation, renal congestion, and sometimes during pregnancy.

Proteinuria of extrarenal origin (which might be considered prerenal or functional if transient) can appear with conditions like myocardial infarction, stroke (apoplexy), traumatic brain injury (TBI), epileptic seizures, severe fever, or in the postoperative period, and usually disappears after the underlying cause is resolved.

 

Pathological (Organic) Renal Proteinuria

This type is due to damage to the structures of the renal nephron (glomeruli or tubules) and is indicative of underlying kidney disease.

 

Glomerular Proteinuria

Glomerular proteinuria develops as a result of damage to the glomerular filter (glomerular basement membrane, podocytes, endothelial cells), leading to impaired filtration and increased passage of plasma proteins (primarily albumin) into the tubular fluid. The amount of protein can range from mild to very heavy (nephrotic range, >3.5 g/day).

Glomerular proteinuria is observed in virtually all kidney diseases that involve glomerular damage, such as:

  • Acute and chronic glomerulonephritis (e.g., IgA nephropathy, membranous nephropathy, focal segmental glomerulosclerosis - FSGS, minimal change disease).
  • Diabetic nephropathy (a common cause of chronic kidney disease and proteinuria).
  • Hypertensive nephrosclerosis (kidney damage due to high blood pressure).
  • Lupus nephritis and other collagen vascular diseases (collagenoses) affecting the kidneys.
  • Amyloidosis.
  • Preeclampsia (toxicosis of pregnant women).
  • Nephrotic syndrome (characterized by heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia).
  • Certain kidney tumors or cysts that affect glomerular function.
  • Gout (can lead to urate nephropathy with glomerular involvement).
  • Chronic potassium deficiency (hypokalemic nephropathy).

 

Tubular Proteinuria

Tubular proteinuria is caused by impaired reabsorption of normally filtered low-molecular-weight proteins (e.g., β2-microglobulin, α1-microglobulin, retinol-binding protein) by the proximal renal tubules. This occurs due to damage or dysfunction of the tubular epithelial cells, often resulting from toxic effects or inherited disorders. Proteinuria is typically mild to moderate (<2 g/day) and consists mainly of these low-molecular-weight proteins rather than albumin.

Tubular proteinuria develops with hereditary (congenital) or acquired tubulopathies, including:

  • Acute tubular necrosis (ATN) due to ischemia or nephrotoxins.
  • Chronic tubulointerstitial nephritis (e.g., due to chronic pyelonephritis, analgesic nephropathy).
  • Acute and chronic renal failure (various causes affecting tubular function).
  • Tubular nephropathies caused by poisoning with heavy metals (e.g., mercury, lead, cadmium).
  • Exposure to other nephrotoxic drugs (e.g., certain antibiotics like aminoglycosides, NSAIDs) or substances.
  • Fanconi syndrome (a generalized proximal tubular dysfunction).
  • Wilson's disease.
  • Certain viral infections affecting tubules.

 

Selectivity of Proteinuria

Depending on the integrity of the glomerular basement membrane and its ability to restrict the passage of proteins of different sizes into the urine, glomerular proteinuria can be classified as selective or non-selective:

  1. Selective Proteinuria: Characterized by the predominant filtration of lower molecular weight proteins, primarily albumin (MW ~69 kDa) and transferrin. This indicates less severe damage to the glomerular filter, where the size-selective barrier is partially compromised but still restricts larger proteins. It is typical of conditions like minimal change disease.
  2. Non-selective Proteinuria: Occurs with more severe glomerular damage, where not only low-molecular-weight proteins but also high-molecular-weight proteins (e.g., immunoglobulins like IgG) pass into the urine. This indicates a significant loss of both size and charge selectivity of the glomerular filter. Low-selective (highly non-selective) proteinuria is observed with pronounced glomerular lesions, for example, in severe forms of chronic nephritis during an acute stage.

Proteinuria selectivity can be further graded as high-, moderate-, or low-selective. A subacute course of glomerular disease is often characterized by moderately selective proteinuria.

 

Microalbuminuria

Microalbuminuria refers to the excretion of small but abnormal amounts of albumin in the urine, typically defined as 30 to 300 mg of albumin per day (or 20-200 µg/min, or an albumin-to-creatinine ratio of 30-300 mg/g). This level is below the detection threshold of standard urine dipsticks for total protein but can be measured by specific immunoassays. Microalbuminuria is noted when the filtration of albumin in the glomeruli is subtly impaired and serves as an important early criterion for nephropathy, particularly in patients with diabetes mellitus and hypertension. It is a marker of early kidney damage and increased cardiovascular risk.

 

Postrenal Proteinuria (Extrarenal Proteinuria)

Postrenal proteinuria is possible as a result of the addition of proteins (such as mucoids, inflammatory exudates, or blood) to the urine as it passes through the urinary tract distal to the kidneys (ureters, bladder, urethra, prostate, seminal vesicles). The amount of protein is usually insignificant and is made up of:

  • Cellular debris from desquamated epithelial cells of the urinary tract.
  • Inflammatory cells (white blood cells) and proteins from infections (cystitis, urethritis, prostatitis).
  • Red blood cells in cases of microhematuria or gross hematuria (e.g., with urinary stones passing through the urinary tract, tumors, or trauma).
  • Mucus secreted by the urinary tract epithelium.
  • Contamination from vaginal secretions.

 

Diagnosis of Proteinuria and Underlying Causes

The detection and quantification of proteinuria are key steps in evaluating kidney health.

  1. Urinalysis (Dipstick and Microscopy):
    • Dipstick Test: A common screening tool. It primarily detects albumin using a colorimetric reaction. Results are typically reported as negative, trace, 1+, 2+, 3+, or 4+. False positives (e.g., highly concentrated or alkaline urine, contamination with antiseptics) and false negatives (e.g., dilute urine, presence of non-albumin proteins like Bence Jones proteins) can occur.
    • Microscopic Examination of Urine Sediment: To look for red blood cells, white blood cells, casts (which can indicate the renal origin of proteinuria), crystals, and bacteria.
  2. Quantitative Protein Measurement:
    • 24-Hour Urine Protein Collection: Historically the gold standard for quantifying daily protein excretion.
    • Spot Urine Protein-to-Creatinine Ratio (UPCR) or Albumin-to-Creatinine Ratio (ACR): A more convenient method using a single spot urine sample. The ratio correlates well with 24-hour protein excretion and is now widely used for screening and monitoring. An ACR is specifically used to detect and quantify albuminuria (including microalbuminuria).
  3. Urine Protein Electrophoresis (UPEP) and Immunofixation: To identify specific types of proteins in the urine, particularly useful for detecting monoclonal proteins (e.g., Bence Jones proteins in multiple myeloma).
  4. Blood Tests:
    • Serum creatinine, BUN, and eGFR to assess kidney function.
    • Serum albumin (low levels may indicate significant protein loss).
    • Serum electrolytes, glucose, HbA1c (for diabetes).
    • Serological tests for autoimmune diseases (e.g., ANA, ANCA, anti-GBM antibodies), hepatitis B/C, HIV if glomerular disease is suspected.
    • Serum protein electrophoresis (SPEP) and immunofixation if monoclonal gammopathy is suspected.
  5. Renal Imaging: Ultrasound, CT, or MRI of the kidneys to evaluate for structural abnormalities, tumors, cysts, or hydronephrosis.
  6. Kidney Biopsy: May be performed if the cause of significant or persistent proteinuria (especially glomerular proteinuria) is unclear after non-invasive investigations, or to guide specific treatment for glomerular diseases.

 

Management Principles for Proteinuria

The management of proteinuria is directed at treating the underlying cause and reducing the amount of protein excretion to slow the progression of kidney disease and reduce cardiovascular risk.

  • Treating the Underlying Condition:
    • Diabetes: Strict glycemic control, blood pressure management (often with ACE inhibitors or ARBs), and lifestyle modifications.
    • Hypertension: Blood pressure control, typically aiming for targets <130/80 mmHg, often using ACE inhibitors or ARBs due to their antiproteinuric effects.
    • Glomerulonephritis: Immunosuppressive therapy (corticosteroids, cytotoxic agents, biologics) for specific types of glomerulonephritis.
    • Infections: Antibiotics for UTIs or pyelonephritis.
    • Multiple Myeloma: Chemotherapy and other specific treatments.
  • Blood Pressure Control: Angiotensin-Converting Enzyme (ACE) inhibitors or Angiotensin II Receptor Blockers (ARBs) are often first-line agents as they reduce intraglomerular pressure and have specific antiproteinuric effects beyond blood pressure lowering.
  • Dietary Modifications:
    • Sodium Restriction: To help control blood pressure and edema.
    • Protein Restriction (Moderate): May be recommended in some cases of chronic kidney disease with proteinuria, under the guidance of a nephrologist and dietitian, to reduce glomerular hyperfiltration.
  • Lifestyle Changes: Weight management, smoking cessation, regular exercise.
  • Management of Complications: Treatment of edema (e.g., with diuretics), hyperlipidemia.

For functional or transient proteinuria, treatment of the underlying trigger (e.g., fever, strenuous exercise) usually leads to resolution. Orthostatic proteinuria typically requires no specific treatment but may warrant periodic monitoring.

 

Differential Diagnosis of Proteinuria by Type and Cause

Type of Proteinuria Primary Protein(s) Excreted Common Causes Typical Amount of Proteinuria
Glomerular (Selective) Mainly Albumin, Transferrin Minimal Change Disease, early Diabetic Nephropathy, Focal Segmental Glomerulosclerosis (some forms) Variable; can be nephrotic range (>3.5 g/day) in minimal change
Glomerular (Non-Selective) Albumin, IgG, other large proteins Membranous Nephropathy, FSGS, advanced Diabetic Nephropathy, Lupus Nephritis, most proliferative Glomerulonephritides Often moderate to heavy; frequently nephrotic range
Tubular Low-Molecular-Weight Proteins (β2-microglobulin, α1-microglobulin, light chains) Acute Tubular Necrosis, Interstitial Nephritis, Fanconi Syndrome, Heavy Metal Poisoning, Drug-induced tubulopathy Usually mild to moderate (<2 g/day)
Overflow (Prerenal) Specific plasma protein in excess (e.g., Bence Jones proteins, Myoglobin, Hemoglobin) Multiple Myeloma, Rhabdomyolysis, Intravascular Hemolysis Variable, can be very high depending on plasma concentration of the overflowing protein
Functional/Transient Mainly Albumin Fever, Strenuous exercise, Orthostatic proteinuria, Dehydration, Emotional stress Usually mild (<1 g/day), transient
Postrenal Mixed proteins, cells, mucus Urinary Tract Infection (cystitis, urethritis, prostatitis), Contamination Usually mild, reflects inflammation/cells rather than filtered protein

 

Clinical Significance and When to Seek Medical Attention

Proteinuria, especially if persistent, is a significant marker of kidney damage and an independent risk factor for the progression of chronic kidney disease (CKD) and cardiovascular disease. Even low levels of persistent albuminuria (microalbuminuria) are associated with increased risks.

Medical attention should be sought if:

  • Protein is detected in the urine on a routine test.
  • Urine appears persistently foamy or frothy (can be a sign of proteinuria).
  • Symptoms of kidney disease develop, such as:
    • Swelling (edema) in the legs, ankles, feet, or around the eyes.
    • Fatigue, weakness.
    • Shortness of breath.
    • Nausea, vomiting, loss of appetite.
    • Changes in urination patterns.
  • There is a known risk factor for kidney disease, such as diabetes, hypertension, or a family history of kidney problems, and regular screening is due.

Early detection and management of proteinuria and its underlying cause are crucial for preventing or slowing the progression of kidney disease and reducing associated complications.

References

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1–150.
  2. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003 Jul 15;139(2):137-47.
  3. Glassock RJ. Is the presence of microalbuminuria a relevant predictor of cardiovascular disease events? Curr Hypertens Rep. 2010 Oct;12(5):364-8.
  4. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998 Nov 12;339(20):1448-56.
  5. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. 1975 Apr;55(4):845-55. (Context for diabetic nephropathy)
  6. Waldherr R, Ritz E. The glomerulus in diabetes. Contrib Nephrol. 1996;118:48-57.
  7. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Proteinuria. Accessed [Current Date]. (Refer to latest NIDDK patient information).
  8. Rose BD, Rennke HG. Renal Pathophysiology: The Essentials. Williams & Wilkins; 1994. Chapter 3: Proteinuria and the Nephrotic Syndrome.